UB Paderborn / Katalog / Suche / in CDI

Tyrosine Kinase Inhibitors. 15. 4-(Phenylamino)quinazoline and 4-(Phenylamino)pyrido[d]pyrimidine Acrylamides as Irreversible Inhibitors of the ATP Binding Site of the Epidermal Growth Factor Receptor

Journal of medicinal chemistry, 1999-05, Vol.42 (10), p.1803-1815

1999

Link zum Volltext

Verfügbarkeit prüfen

Structure-Based Design of a Potent, Selective, and Irreversible Inhibitor of the Catalytic Domain of the erbB Receptor Subfamily of Protein Tyrosine Kinases

Journal of medicinal chemistry, 1997-03, Vol.40 (7), p.1130-1135

1997

Link zum Volltext

Verfügbarkeit prüfen

Substrate Specificity of the Protein Tyrosine Phosphatases

Proceedings of the National Academy of Sciences - PNAS, 1993-05, Vol.90 (10), p.4446-4450

1993

Link zum Volltext

Verfügbarkeit prüfen

Sequence specificity in recognition of the epidermal growth factor receptor by protein tyrosine phosphatase 1B

The Journal of biological chemistry, 1993-11, Vol.268 (31), p.23634-23639

1993

Link zum Volltext

Verfügbarkeit prüfen

Specific, Irreversible Inactivation of the Epidermal Growth Factor Receptor and erbB2, by a New Class of Tyrosine Kinase Inhibitor

Proceedings of the National Academy of Sciences - PNAS, 1998-09, Vol.95 (20), p.12022-12027

1998

Link zum Volltext

Verfügbarkeit prüfen

Pyrido[2,3-d]pyrimidin-7-ones as Specific Inhibitors of Cyclin-Dependent Kinase 4

Journal of medicinal chemistry, 2005-04, Vol.48 (7), p.2371-2387

2005

Link zum Volltext

Verfügbarkeit prüfen

Determinants of Substrate Recognition in the Protein-tyrosine Phosphatase, PTP1 (∗)

The Journal of biological chemistry, 1996-03, Vol.271 (10), p.5386-5392

1996

Link zum Volltext

Verfügbarkeit prüfen

Tyrosine Kinase Inhibitors. 3. Structure-Activity Relationships for Inhibition of Protein Tyrosine Kinases by Nuclear-Substituted Derivatives of 2,2'-Dithiobis(1-methyl-N-phenyl-1H-indole-3-carboxamide)

Journal of medicinal chemistry, 1994-06, Vol.37 (13), p.2033-2042

1994

Link zum Volltext

Verfügbarkeit prüfen

Tyrosine kinase inhibitors. 1. Structure-activity relationships for inhibition of epidermal growth factor receptor tyrosine kinase activity by 2,3-dihydro-2-thioxo-1H-indole-3-alkanoic acids and 2,2'-dithiobis(1H-indole-3-alkanoic acids)

Journal of medicinal chemistry, 1993-08, Vol.36 (17), p.2459-2469

1993

Link zum Volltext

Verfügbarkeit prüfen

Structure–activity relationships for 2-anilino-6-phenylpyrido[2,3- d]pyrimidin-7(8 H)-ones as inhibitors of the cellular checkpoint kinase Wee1

Bioorganic & medicinal chemistry letters, 2005-04, Vol.15 (7), p.1931-1935

2005

Link zum Volltext

Verfügbarkeit prüfen

Identification of amino acids in the N-terminal SH2 domain of phospholipase C gamma 1 important in the interaction with epidermal growth factor receptor

Biochemistry (Easton), 1994-12, Vol.33 (49), p.14671

1994

Link zum Volltext

Verfügbarkeit prüfen

2-Aminoquinazoline inhibitors of cyclin-dependent kinases

Bioorganic & medicinal chemistry letters, 2005-09, Vol.15 (17), p.3881-3885

2005

Link zum Volltext

Verfügbarkeit prüfen

Differentiation of peptide molecular recognition by phospholipase Cγ‐1 Src homology‐2 domain and a mutant Tyr phosphatase PTP1bC215S

Protein science, 1995-01, Vol.4 (1), p.13-20

1995

Link zum Volltext

Verfügbarkeit prüfen

Design of a potent peptide inhibitor of the epidermal growth factor receptor tyrosine kinase utilizing sequences based on the natural phosphorylation sites of phospholipase C-gamma 1

Peptides (New York, N.Y. : 1980), 1994, Vol.15 (6), p.951-957

1994

Link zum Volltext

Verfügbarkeit prüfen

Design of a potent peptide inhibitor of the epidermal growth factor receptor tyrosine kinase utilizing sequences based on the natural phosphorylation sites of phospholipase C-γ1

Peptides (New York, N.Y. : 1980), 1994, Vol.15 (6), p.951-957

1994

Link zum Volltext

Verfügbarkeit prüfen

Design of a potent peptide inhibitor of the epidermal growth factor receptor tyrosine kinase utilizing sequences based on the natural phsphorylation sites of phospholipase C-γ1

Peptides (New York, N.Y. : 1980), 1994, Vol.15 (6), p.951-957

1994

Link zum Volltext

Verfügbarkeit prüfen

Tyrosine kinase inhibitors. III: Structure-activity relationships for inhibition of protein tyrosine kinase by nuclear-substituted derivatives of 2,2'-dithiobis(1-methyl-N-phenyl-1H-indole-3-carboxamide)

Journal of medicinal chemistry, 1994, Vol.37 (13), p.2033-2042

1994

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of binding of phospholipase C gamma 1 SH2 domains to phosphorylated epidermal growth factor receptor by phosphorylated peptides

International journal of peptide and protein research, 1993-09, Vol.42 (3), p.240-248

1993

Link zum Volltext

Verfügbarkeit prüfen

Tyrosine kinase inhibitors. I: Structure-activity relationships for inhibition of epidermal growth factor receptor tyrosine kinase activity by 2,3-dihydro-2-thioxo-1H-indole-3-alkanoic acids and 2,2'-dithiobis(1H-indole-3-alkanoic acids)

Journal of medicinal chemistry, 1993, Vol.36 (17), p.2459-2469

1993

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of binding of phospholipase Cγ1 SH2 domains to phosphorylated epidermal growth factor receptor by phosphorylated peptides

International Journal of Peptide and Protein Research, 1993-09, Vol.42 (3), p.240-248

1993

Link zum Volltext

Verfügbarkeit prüfen

Substrates specificity of the protein tyrosine phosphatases

Proceedings of the National Academy of Sciences - PNAS, 1993, Vol.90 (10), p.4446-4450

1993

Link zum Volltext

Verfügbarkeit prüfen

ChemInform Abstract: Tyrosine Kinase Inhibitors. Part 3. Structure-Activity Relationships for Inhibition of Protein Tyrosine Kinases by Nuclear-Substituted Derivatives of 2,2′-Dithiobis(1-methyl-N-phenyl-1H-indole-3- carboxamide)

ChemInform, 1994-12, Vol.25 (50), p.no-no

1994

Link zum Volltext

Verfügbarkeit prüfen

Pyrido[2,3-d]pyrimidin-7-one Inhibitors of Cyclin-Dependent Kinases

Journal of medicinal chemistry, 2000-11, Vol.43 (24), p.4606-4616

2000

Link zum Volltext

Verfügbarkeit prüfen

Cell cycle and biochemical effects of PD 0183812. A potent inhibitor of the cyclin D-dependent kinases CDK4 and CDK6

The Journal of biological chemistry, 2001-05, Vol.276 (20), p.16617-16623

2001

Link zum Volltext

Verfügbarkeit prüfen

Attentional Asymmetry in Schizophrenia: Disengagement and Inhibition of Return Deficits

Neuropsychology, 2001-07, Vol.15 (3), p.361-370

2001

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Tyrosine Kinase Inhibitors. 15. 4-(Phenylamino)quinazoline and 4-(Phenylamino)pyrido[d]pyrimidine Acrylamides as Irreversible Inhibitors of the ATP Binding Site of the Epidermal Growth Factor Receptor

Structure-Based Design of a Potent, Selective, and Irreversible Inhibitor of the Catalytic Domain of the erbB Receptor Subfamily of Protein Tyrosine Kinases

Substrate Specificity of the Protein Tyrosine Phosphatases

Sequence specificity in recognition of the epidermal growth factor receptor by protein tyrosine phosphatase 1B

Specific, Irreversible Inactivation of the Epidermal Growth Factor Receptor and erbB2, by a New Class of Tyrosine Kinase Inhibitor

Pyrido[2,3-d]pyrimidin-7-ones as Specific Inhibitors of Cyclin-Dependent Kinase 4

Determinants of Substrate Recognition in the Protein-tyrosine Phosphatase, PTP1 (∗)

Tyrosine Kinase Inhibitors. 3. Structure-Activity Relationships for Inhibition of Protein Tyrosine Kinases by Nuclear-Substituted Derivatives of 2,2'-Dithiobis(1-methyl-N-phenyl-1H-indole-3-carboxamide)

Tyrosine kinase inhibitors. 1. Structure-activity relationships for inhibition of epidermal growth factor receptor tyrosine kinase activity by 2,3-dihydro-2-thioxo-1H-indole-3-alkanoic acids and 2,2'-dithiobis(1H-indole-3-alkanoic acids)

Structure–activity relationships for 2-anilino-6-phenylpyrido[2,3- d]pyrimidin-7(8 H)-ones as inhibitors of the cellular checkpoint kinase Wee1

Identification of amino acids in the N-terminal SH2 domain of phospholipase C gamma 1 important in the interaction with epidermal growth factor receptor

2-Aminoquinazoline inhibitors of cyclin-dependent kinases

Differentiation of peptide molecular recognition by phospholipase Cγ‐1 Src homology‐2 domain and a mutant Tyr phosphatase PTP1bC215S

Design of a potent peptide inhibitor of the epidermal growth factor receptor tyrosine kinase utilizing sequences based on the natural phosphorylation sites of phospholipase C-gamma 1

Design of a potent peptide inhibitor of the epidermal growth factor receptor tyrosine kinase utilizing sequences based on the natural phosphorylation sites of phospholipase C-γ1

Design of a potent peptide inhibitor of the epidermal growth factor receptor tyrosine kinase utilizing sequences based on the natural phsphorylation sites of phospholipase C-γ1

Tyrosine kinase inhibitors. III: Structure-activity relationships for inhibition of protein tyrosine kinase by nuclear-substituted derivatives of 2,2'-dithiobis(1-methyl-N-phenyl-1H-indole-3-carboxamide)

Inhibition of binding of phospholipase C gamma 1 SH2 domains to phosphorylated epidermal growth factor receptor by phosphorylated peptides

Tyrosine kinase inhibitors. I: Structure-activity relationships for inhibition of epidermal growth factor receptor tyrosine kinase activity by 2,3-dihydro-2-thioxo-1H-indole-3-alkanoic acids and 2,2'-dithiobis(1H-indole-3-alkanoic acids)

Inhibition of binding of phospholipase Cγ1 SH2 domains to phosphorylated epidermal growth factor receptor by phosphorylated peptides

Substrates specificity of the protein tyrosine phosphatases

ChemInform Abstract: Tyrosine Kinase Inhibitors. Part 3. Structure-Activity Relationships for Inhibition of Protein Tyrosine Kinases by Nuclear-Substituted Derivatives of 2,2′-Dithiobis(1-methyl-N-phenyl-1H-indole-3- carboxamide)

Pyrido[2,3-d]pyrimidin-7-one Inhibitors of Cyclin-Dependent Kinases

Cell cycle and biochemical effects of PD 0183812. A potent inhibitor of the cyclin D-dependent kinases CDK4 and CDK6

Attentional Asymmetry in Schizophrenia: Disengagement and Inhibition of Return Deficits

Suchergebnisse filtern